Summary
In order to investigate the effects of simvastatin on secretion and mRNA expression of interleukin-6 (IL-6) and adiponectin in 3T3-L1 adipocytes, mouse 3T3-L1 adipocytes were stimulated with lipopolysaccharide (LPS). Production and mRNA expression of IL-6 and adiponectin in 3T3-L1 adipocytes were measured using enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase polymerase chain reaction (RT-PCR), respectively. The results showed that simvastatin could significantly suppress LPS-induced IL-6 production and mRNA expression in adipocytes (P<0.05), but increase the LPS-induced adiponectin secretion and mRNA expression in a dose-dependent manner (P<0.05). It was suggested that simvastatin could exert beneficial effects on prevention of obesity-induced metabolic changes in adipocytes.
Similar content being viewed by others
References
Wellen K E, Hotamisligil G S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest, 2003,112:1785–1788
Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci, 1999,892:146–154
Maeda K, Okubo K, Shimomura I et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun, 1996,221:286–289
Woods A, Brull D J, Humphries S E et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J, 2000,21:1574–1583
Bernlohr D A, Angus C W, Lane M D et al. Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci U S A, 1984,81:5468–5472
Das U N. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition, 2005,21:762–773
Yudkin J S, Stehouwer C D, Emeis J J et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol, 1999,19:972–978
Bullo M, Garcia-Lorda P, Megias I et al. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res, 2003,11:525–531
Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem, 2003,278:45 777–45 784
Fasshauer M, Klein J, Lossner U et al. Interlenkin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone and IL-6 in 3T3-L1 adipocytes. Horm Metab Res, 2003,35:147–152
Fried S K, Bunkin D A, Greenberg A S et al. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab, 1998,83:847–850
Chen C, Li Z, Li J. Anti-inflammatory effect of cerivastatin in vascular injury independent of serum cholesterol and blood pressure lowering effects in mouse model. Chin J Traumatol (Chinese), 2002,5:294–298
Author information
Authors and Affiliations
Additional information
YIN Xiaoming, male, born in 1975, Doctor in Charge
Rights and permissions
About this article
Cite this article
Yin, X., Tu, L. & Yang, H. Effect of simvastatin on IL-6 and adiponectin secretion and mRNA expression in 3T3-L1 adipocytes. J. Huazhong Univ. Sc. Technol. 27, 248–251 (2007). https://doi.org/10.1007/s11596-007-0308-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-007-0308-6